Back to Search Start Over

Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.

Authors :
Espinel-Ingroff A
Alvarez-Fernandez M
Cantón E
Carver PL
Chen SC
Eschenauer G
Getsinger DL
Gonzalez GM
Govender NP
Grancini A
Hanson KE
Kidd SE
Klinker K
Kubin CJ
Kus JV
Lockhart SR
Meletiadis J
Morris AJ
Pelaez T
Quindós G
Rodriguez-Iglesias M
Sánchez-Reus F
Shoham S
Wengenack NL
Borrell Solé N
Echeverria J
Esperalba J
Gómez-G de la Pedrosa E
García García I
Linares MJ
Marco F
Merino P
Pemán J
Pérez Del Molino L
Roselló Mayans E
Rubio Calvo C
Ruiz Pérez de Pipaon M
Yagüe G
Garcia-Effron G
Guinea J
Perlin DS
Sanguinetti M
Shields R
Turnidge J
Source :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Nov; Vol. 59 (11), pp. 6725-32. Date of Electronic Publication: 2015 Aug 17.
Publication Year :
2015

Abstract

Neither breakpoints (BPs) nor epidemiological cutoff values (ECVs) have been established for Candida spp. with anidulafungin, caspofungin, and micafungin when using the Sensititre YeastOne (SYO) broth dilution colorimetric method. In addition, reference caspofungin MICs have so far proven to be unreliable. Candida species wild-type (WT) MIC distributions (for microorganisms in a species/drug combination with no detectable phenotypic resistance) were established for 6,007 Candida albicans, 186 C. dubliniensis, 3,188 C. glabrata complex, 119 C. guilliermondii, 493 C. krusei, 205 C. lusitaniae, 3,136 C. parapsilosis complex, and 1,016 C. tropicalis isolates. SYO MIC data gathered from 38 laboratories in Australia, Canada, Europe, Mexico, New Zealand, South Africa, and the United States were pooled to statistically define SYO ECVs. ECVs for anidulafungin, caspofungin, and micafungin encompassing ≥97.5% of the statistically modeled population were, respectively, 0.12, 0.25, and 0.06 μg/ml for C. albicans, 0.12, 0.25, and 0.03 μg/ml for C. glabrata complex, 4, 2, and 4 μg/ml for C. parapsilosis complex, 0.5, 0.25, and 0.06 μg/ml for C. tropicalis, 0.25, 1, and 0.25 μg/ml for C. krusei, 0.25, 1, and 0.12 μg/ml for C. lusitaniae, 4, 2, and 2 μg/ml for C. guilliermondii, and 0.25, 0.25, and 0.12 μg/ml for C. dubliniensis. Species-specific SYO ECVs for anidulafungin, caspofungin, and micafungin correctly classified 72 (88.9%), 74 (91.4%), 76 (93.8%), respectively, of 81 Candida isolates with identified fks mutations. SYO ECVs may aid in detecting non-WT isolates with reduced susceptibility to anidulafungin, micafungin, and especially caspofungin, since testing the susceptibilities of Candida spp. to caspofungin by reference methodologies is not recommended.<br /> (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)

Details

Language :
English
ISSN :
1098-6596
Volume :
59
Issue :
11
Database :
MEDLINE
Journal :
Antimicrobial agents and chemotherapy
Publication Type :
Academic Journal
Accession number :
26282428
Full Text :
https://doi.org/10.1128/AAC.01250-15